Skip to main content
. 2016 Dec 3;8(5):7559–7571. doi: 10.18632/oncotarget.13791

Figure 6. The effects of etanercept and adalimumab on NFκB-associated acetyltransferases in Th17-polarized cells.

Figure 6

Etanercept (1 μg/mL) decreased the recruitment of the NFκB-associated acetyltransferases (A) p300, (B) CBP and (C) PCAF in Th17-polarized cells induced from purified CD4+ T cells (naïve T cells). Adalimumab (10 μg/mL) decreased the recruitment of the NFκB-associated acetyltransferases (D) p300, (E) CBP and (F) PCAF in Th17-polarized cells. The standard deviations of the ChIP data were calculated from four independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001.